Duobrii™ (halobetasol propionate and tazarotene) – New drug approval
April 25, 2019 - Bausch Health announced the FDA approval of Duobrii (halobetasol propionate and tazarotene) lotion, for the topical treatment of plaque psoriasis in adults.
Download PDF
